Quenton Rashawn Bubb continues to value the complex, complementary nature of work on parallel paths -- not just as a musician/academic, but now on the path to his career.
Stanford Medicine researchers take a unique approach to refine engineered immune cells meant to kill cancer.
Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.
'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.
In this In the Spotlight, hematologist/oncologist Gabriel Mannis talks about his passion for medicine and his experience working at Sesame Street.
Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.
After a year of baffling symptoms, two Stanford specialists pieced together the puzzle of this woman's disease.
Monitoring changes in the levels of circulating bits of tumor DNA may help some lymphoma patients avoid unnecessary chemotherapy, Stanford researchers find.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
